Abstract
Unbiased species-level identification of coagulase-negative staphylococci (CoNS) using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) identified Staphylococcus lugdunensis to be a more commonly isolated CoNS in our laboratory than previously observed. It has also highlighted the possibility of vertical transmission.
TEXT
Coagulase-negative staphylococci (CoNS) have been mostly considered insignificant contaminants when isolated from clinical samples. This, in turn, has led to a lack of universal agreement on the importance of identifying them to the species level (1, 2).
The introduction of matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) to routine clinical laboratories has made it feasible to rapidly and accurately identify clinical isolates without adding significant costs (3, 4).
MALDI-TOF MS has been in routine diagnostic use at our laboratory since 2010. We identify all clinical isolates, irrespective of site or clinical details. In an attempt to assess the value of unbiased species-level identification of CoNS, we investigated the epidemiology and clinical correlates associated with the isolation of Staphylococcus lugdunensis, a relatively virulent CoNS that causes a spectrum of disease similar to that of Staphylococcus aureus (5).
S. lugdunensis isolates were identified from the laboratory information management system (LIMS). Specimen request forms, electronic clinical records, and written clinical records were reviewed (for hospital and community samples). Only the isolates with a MALDI-TOF MS spectral score of ≥2 (which reflects high confidence in identification to the species level) were included. A total of 20,806 CoNS isolates were identified using MALDI-TOF MS in a 24-month period. Of those, 559 were identified as S. lugdunensis (Table 1), whereas 31 isolates were identified in the preceding 24 months using conventional techniques. Duplicate results from the same patient were removed (n = 81). In total, 478 individual isolates were reviewed (Table 2). The clinical data we collected included demographics, sample type, sample site, clinical symptoms, diagnosis, comorbidities, antibiotic usage, surgical procedures, and indwelling and prosthetic devices.
TABLE 1.
Species | No. of isolates | % |
---|---|---|
Staphylococcus epidermidis | 10,550 | 50.704 |
Staphylococcus haemolyticus | 4,103 | 19.720 |
Staphylococcus hominis | 1,787 | 8.589 |
Staphylococcus capitis | 1,615 | 7.762 |
Staphylococcus warneri | 702 | 3.374 |
Staphylococcus lugdunensis | 559 | 2.687 |
Staphylococcus simulans | 360 | 1.730 |
Staphylococcus saprophyticus | 270 | 1.298 |
Staphylococcus caprae | 157 | 0.755 |
Staphylococcus pettenkoferi | 143 | 0.687 |
Staphylococcus pasteuri | 115 | 0.553 |
Staphylococcus sciuri | 103 | 0.495 |
Staphylococcus cohnii | 100 | 0.481 |
Staphylococcus intermedius | 47 | 0.226 |
Staphylococcus sp.a | 40 | 0.192 |
Staphylococcus condimenti | 38 | 0.183 |
Staphylococcus auricularis | 33 | 0.159 |
Staphylococcus schleiferi | 33 | 0.159 |
Staphylococcus sp. | 19 | 0.091 |
Staphylococcus equorum | 11 | 0.053 |
Staphylococcus xylosus | 7 | 0.034 |
Staphylococcus carnosus | 4 | 0.019 |
Staphylococcus saccharolyticus | 3 | 0.014 |
Staphylococcus piscifermentans | 2 | 0.010 |
Staphylococcus pseudintermedius | 2 | 0.010 |
Staphylococcus arlettae | 1 | 0.005 |
Staphylococcus delphini | 1 | 0.005 |
Staphylococcus felis | 1 | 0.005 |
Total | 20,806 | 100 |
Nontyped strain having high similarity to unpublished isolate AY953148.1, “Staphylococcus croceolyticus.”
TABLE 2.
Diagnosis | No. | % |
---|---|---|
None | 80 | 16.7 |
Superficial abscess | 99 | 20.7 |
Cellulitis | 13 | 2.7 |
Necrotizing fasciitis | 1 | 0.2 |
Device infection | 8 | 1.7 |
Osteomyelitis | 6 | 1.3 |
Endocarditis | 2 | 0.4 |
Wound infection | 124 | 25.9 |
Septic arthritis | 1 | 0.2 |
Urinary tract infection | 1 | 0.2 |
Upper respiratory tract infection | 8 | 1.7 |
Central venous catheter-related infection | 4 | 0.8 |
Infected sebaceous cyst | 18 | 3.8 |
Neonatal sepsis | 4 | 0.8 |
Lower respiratory tract infection | 7 | 1.5 |
Boil | 1 | 0.2 |
Other | 100 | 21 |
Pleural effusion | 1 | 0.2 |
Total | 478 | 100.0 |
A total of 121 isolates (25.3%) were from primary care. The male-to-female ratio was 0.84, and the median age was 42 years, with a calculated incidence of 30.5 cases per 100,000 persons in the local population. Twenty-two isolates (4.6%) were from neonates (<30 days old), with 10 isolated in the first 7 days of life. Of the 22 neonatal isolates, 5 were from sterile sites (blood, n = 3; cerebrospinal fluid [CSF], n = 1; and urine, n = 1) and the rest were from swabs (Table 3).
TABLE 3.
Age (days) | Sample type | Delivery mode |
---|---|---|
0 | Swab | Spontaneous vertex |
1 | Blood culture | Emergency CSa |
1 | Swab | Emergency CS |
1 | Blood culture | Emergency CS |
1 | Gastric aspirate | Emergency CS |
3 | Blood culture | Spontaneous vertex |
4 | Urine | Elective CS |
5 | Umbilical swab | Emergency CS |
5 | CSF | Spontaneous vertex |
7 | Umbilical swab | Spontaneous vertex |
12 | Umbilical swab | Emergency CS |
18 | Nasopharyngeal swab | Unknown |
19 | Swab | Unknown |
20 | Swab | Emergency CS |
25 | Respiratory | Spontaneous vertex |
29 | Sputum | Unknown |
30 | Endotracheal tube tip | Emergency CS |
30 | Sputum | Unknown |
30 | Respiratory | Spontaneous breech |
30 | Nasopharyngeal swab | Unknown |
30 | Respiratory | Unknown |
30 | Swab | Spontaneous vertex |
CS, Cesarean section.
The commonest infections were skin and soft tissue infections (SSTI), with a total of 237 episodes; of these, 99 (41.8%) were abscesses, and 79 (79.8%) required drainage. Abscesses were equally distributed between the upper and lower halves of the body. The commonest abscess sites were the axilla (n = 16) and neck (n = 10) in the upper torso and the pelvis (n = 10) and thighs (n = 10) in the lower body. Vaginal abscesses and infected Bartholin cysts were diagnosed in 7 patients, in addition to 34 isolates from vaginal swabs, taken either as part of a routine pregnancy examination or with the clinical detail of vaginal discharge. A total of 35 isolates were from surgical site infections.
Nineteen episodes of S. lugdunensis bacteremia were identified. The clinical significance of 7 of them was doubtful, as the patients were not specifically treated for infection without an adverse outcome. Of the remaining 12 patients, 2 had endocarditis, 1 had native valve endocarditis (NVE), and 1 had prosthetic valve endocarditis (PVE). Three bacteremic patients had respiratory tract infections. One patient each had osteomyelitis, cellulitis, and a wound infection. Three blood cultures were from neonates with early neonatal sepsis. During the same period, CoNS (other species) were isolated in blood cultures from 139 neonates, predominately from preterm infants with suspected late sepsis. An isolate from the CSF of a neonate was considered a likely contaminant due to normal cell counts in the CSF. Ten urine samples, 70% of which were from women, were positive for S. lugdunensis. Twenty-two isolates were obtained from around the breast, 7 (32%) from abscesses, 5 from postsurgical wound swabs, and 1 from an infected breast implant; the remaining isolates had insufficient clinical details. Twenty-seven (5.6%) patients had prosthetic devices in situ (including intravascular catheters and orthopedic hardware). Data about the antibiotics prescribed were available for 202 patients, 136 (67.3%) of whom were receiving monotherapy; the most commonly prescribed antibiotics were flucloxacillin (n = 51) and amoxicillin-clavulanic acid (n = 44).
During this period, antibiotic susceptibility testing was reserved for selected isolates. Of the 41 isolates for which antibiotic susceptibilities were tested, 31 had MICs available; the remaining 10 had sensitivity testing by disk diffusion methods. None of the isolates had a cefoxitin MIC of >4 mg/liter (isolates with cefoxitin MIC values of >4 mg/liter are considered methicillin resistant, mostly due to the presence of the mecA gene) (6, 7). Three isolates showed macrolide resistance, and one isolate was glycopeptide resistant.
With unbiased species-level identification using MALDI-TOF MS, S. lugdunensis is the 6th commonest CoNS isolate in our laboratory. Previous investigators either overestimated (8) or underestimated (6) the incidence of S. lugdunensis in clinical isolates. As previously described, it is mostly isolated from SSTI (9). We also recognized possible vaginal carriage, which may represent a source of vertical transmission, highlighted by the isolation of S. lugdunensis from 22 neonates in our cohort (Table 3). A recent prospective study demonstrated a doubtful clinical significance of S. lugdunensis isolated from a pediatric population; however, selection bias cannot be excluded, and 3 of the 6 isolates identified were from neonates (10). S. lugdunensis has also been isolated from sterile amniotic fluid (11). The possibility of vaginal colonization and neonatal sepsis requires further examination, as this has been demonstrated with other organisms such as group B streptococci (12). Apart from the possibility of vaginal carriage and vertical transmission, our results mirror those of previous findings by Böcher et al. (9), showing SSTI as the primary pathology and abscess formation as a common finding. Most other CoNS have not been associated with abscesses, due to the absence of the necessary virulence factors coagulase and protein A (13). Although these two factors are absent from S. lugdunensis, its ability to cause abscesses has been demonstrated previously (14, 15). The presence of an iron-regulated surface determinant protein, common only to S. lugdunensis and S. aureus (16, 17), and a potent cytolytic streptolysin S-like toxin suggests the capacity for skin colonization and possible virulence (16, 18).
Despite the reputation of S. lugdunensis causing aggressive endocarditis, our findings support those from other reports suggesting that bacteremia does not necessarily always equate to a clinical syndrome or sepsis (5, 19, 20).
The limitations of our study include the retrospective data collection, which may not reflect accurate diagnoses and definitions. In addition, the presence of sampling bias cannot be excluded, as most samples are sent due to suspected infections. Attributing causality for CoNS, including S. lugdunensis, remains difficult, especially when the majority of the samples are from skin swabs, in which differentiation between pathogen and commensal is difficult. Further studies are necessary to refute or confirm these observations.
ACKNOWLEDGMENTS
We thank our biomedical scientists for their continuous lab support. We also thank D. Nikolakopoulos for help with the data entry and Z. Babiker, A. Sivaramakrishnan, K. Kranzer, and A. Sefton for reviewing the manuscript.
No funding was required for this work, and we have no conflicts to declare.
REFERENCES
- 1.Pfaller MA, Herwaldt LA. 1988. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1:281–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Oren I, Merzbach D. 1990. Clinical and epidemiological significance of species identification of coagulase-negative staphylococci in a microbiological laboratory. Isr J Med Sci 26:125–128. [PubMed] [Google Scholar]
- 3.Patel R. 2013. Matrix-assisted laser desorption ionization–time of flight mass spectrometry in clinical microbiology. Clin Infect Dis 57:564–572. doi: 10.1093/cid/cit247. [DOI] [PubMed] [Google Scholar]
- 4.Dubois D, Leyssene D, Chacornac JP, Kostrzewa M, Schmit PO, Talon R, Bonnet R, Delmas J. 2010. Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 48:941–945. doi: 10.1128/JCM.00413-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Frank KL, Del Pozo JL, Patel R. 2008. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 21:111–133. doi: 10.1128/CMR.00036-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tan TY, Ng SY, He J. 2008. Microbiological characteristics, presumptive identification, and antibiotic susceptibilities of Staphylococcus lugdunensis. J Clin Microbiol 46:2393–2395. doi: 10.1128/JCM.00740-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.CLSI. 2007. Performance standards for antimicrobial susceptibility testing, vol 27 Approved standard M100-S17. CLSI, Wayne, PA. [Google Scholar]
- 8.Herchline TE, Ayers LW. 1991. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 29:419–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Böcher S, Tønning B, Skov RL, Prag J. 2009. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. J Clin Microbiol 47:946–950. doi: 10.1128/JCM.01024-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.German GJ, Wang B, Bernard K, Stewart N, Chan F, Pacheco AL, Wiebe D, Burdz T, Slinger R. 2013. Staphylococcus lugdunensis: low prevalence and clinical significance in a pediatric microbiology laboratory. Pediatr Infect Dis J 32:87–89. doi: 10.1097/INF.0b013e3182755f58. [DOI] [PubMed] [Google Scholar]
- 11.Marchocki Z, Collins K, Lehane E, Reilly PO, O'Donoghue K. 2013. Staphylococcus lugdunensis cultured from the amniotic fluid at caesarean section. PLoS One 8:e56373. doi: 10.1371/journal.pone.0056373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dillon HC, Khare S, Gray BM. 1987. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 110:31–36. doi: 10.1016/S0022-3476(87)80283-4. [DOI] [PubMed] [Google Scholar]
- 13.Cheng AG, DeDent AC, Schneewind O, Missiakas D. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 19:225–232. doi: 10.1016/j.tim.2011.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lambe DW, Ferguson KP, Keplinger JL, Gemmell CG, Kalbfleisch JH. 1990. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol 36:455–463. doi: 10.1139/m90-080. [DOI] [PubMed] [Google Scholar]
- 15.Ferguson KP, Lambe DW, Keplinger JL, Kalbfleisch JH. 1991. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can J Microbiol 37:722–724. doi: 10.1139/m91-124. [DOI] [PubMed] [Google Scholar]
- 16.Zapotoczna M, Heilbronner S, Speziale P, Foster TJ. 2012. Iron-regulated surface determinant (Isd) proteins of Staphylococcus lugdunensis. J Bacteriol 194:6453–6467. doi: 10.1128/JB.01195-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Heilbronner S, Holden MTG, van Tonder A, Geoghegan JA, Foster TJ, Parkhill J, Bentley SD. 2011. Genome sequence of Staphylococcus lugdunensis N920143 allows identification of putative colonization and virulence factors. FEMS Microbiol Lett 322:60–67. doi: 10.1111/j.1574-6968.2011.02339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Molloy EM, Cotter PD, Hill C, Mitchell DA, Ross RP. 2011. Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol 9:670–681. doi: 10.1038/nrmicro2624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Fadel HJ, Patel R, Vetter EA, Baddour LM. 2011. Clinical significance of a single Staphylococcus lugdunensis-positive blood culture. J Clin Microbiol 49:1697–1699. doi: 10.1128/JCM.02058-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kleiner E, Monk AB, Archer GL, Forbes BA. 2010. Clinical significance of Staphylococcus lugdunensis isolated from routine cultures. Clin Infect Dis 51:801–803. doi: 10.1086/656280. [DOI] [PubMed] [Google Scholar]